Kynam Capital Management, LP

Company	Share, %
2seventy bio, Inc.	11.58
Burning Rock Biotech Limited	11.01
Syndax Pharmaceuticals, Inc.	9.13
Celldex Therapeutics, Inc.	8.93
CytomX Therapeutics, Inc.	5.29
Cullinan Oncology, Inc.	5.27
Vera Therapeutics, Inc.	4.81
Cogent Biosciences, Inc.	3.8
BioCryst Pharmaceuticals, Inc.	3.73
MorphoSys AG	2.81
Caribou Biosciences, Inc.	2.59
Amarin	1.87
Prelude Therapeutics Incorporated	1.8
ProQR Therapeutics N.V.	1.49
Sutro Biopharma, Inc.	0.56